Earnings Call for Q4FY21 of Marksans Pharma
Conference Call with Marksans Pharma Management and Analysts on Q4FY21 Performance and Outlook. Listen to the full earnings transcript.07-06-2021
07-06-2021
Accumulate Marksans Pharma; target of Rs 86: Arihant Capital
Arihant Capital recommended Accumulate rating on Marksans Pharma with a target price of Rs 86 in its research report dated Jun 01, 2021.01-06-2021
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith Financial Results of the Company for the financial year ended 31st March, 2021 published today i.e. 1 June, 2021 in the Business Standard (English) and Tarun Bharat (Marathi) newspapers.01-06-2021
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Attached pl find a News Release dated 31st May, 202131-05-2021
MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation
Attached pl find Investors Presentation for the year ended 31st March, 202131-05-2021
MARKSANS PHARMA LTD. - 524404 - Outcome Of Board Meeting
This is to inform you that the Board of Directors of the Company has, at its meeting held today i.e. Monday, 31st May, 2021 at Mumbai, recommended dividend of Rs. 0.25 (Rupees Zero and Paise Twenty Five) i.e. 25% per equity share of Re. 1/- each face value for the financial year ended 31st March, 2021, subject to approval of the shareholders in the ensuing Annual General Meeting.31-05-2021
MARKSANS PHARMA LTD. - 524404 - Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2021 And Auditors Report Thereon.
In terms of Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Audited Financial Results (both Standalone and Consolidated) for the quarter and financial year ended 31st March, 2021 approved by the Board of Directors at its meeting held today i.e. 31st May, 2021 along with Auditors Report thereon. The meeting commenced at 11:00 a.m. and concluded at 12:25 p.m. In this connection, we hereby confirm that the Statutory Auditors have given their reports on the Audited Annual Financial Results for the financial year ended 31st March, 2021 (both Standalone and Consolidated) with unmodified opinion.31-05-2021
Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith Notice of the Board Meeting published today i.e. 25th May, 2021 in the Business Standard (English) and Tarun Bharat (Marathi) newspapers.25-05-2021